MedPath

Cemented Acetabular Cups Clinical Study

Not Applicable
Completed
Conditions
Total Hip Arthroplasty
Interventions
Device: Mueller cemented cups
Registration Number
NCT04831918
Lead Sponsor
Limacorporate S.p.a
Brief Summary

This clinical study has the aim to evaluate clinical, radiographic, patient-reported outcomes of total hip arthroplasty with the implant of Mueller cemented acetabular cups up to 2 years after surgery, in order to assess the performance of the device. Furthermore, it aims to collect short-term survivorship of the implant and the incidence of early complications.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
45
Inclusion Criteria
  1. The patient has participated in the Informed Consent process and has signed the Informed Consent form previously approved by the Ethics Committee;

  2. The patient diagnosis is one or more of the following:

    • Patient with advanced articular destruction generated by primary degenerative or post-traumatic arthrosis or rheumatoid arthritis;
    • Patient with avascular necrosis of the femoral head or fracture of the femoral neck;
    • Patient with congenital or acquired deformity;
    • Patient with failures of previous operations, like osteosynthesis, articular reconstruction, arthrodesis, hemi-arthroplasty or total arthroplasty.
  3. The patient is willing and able to complete scheduled follow-up evaluations as described in the Patient Information Sheet;

Exclusion Criteria

The patient should be excluded from the study if he/she meets any of the following criteria, which reflect the cemented acetabular cup contraindication for use:

  1. Acute or chronic infections, local or systemic infections;
  2. Serious muscular, neurological or vascular diseases affecting the concerned limb;
  3. Any concomitant disease and dependence that might affect the implanted prosthesis;
  4. Allergy to material;
  5. Metal-on-metal systems: patients with renal impairment.
  6. Patient's age<18
  7. Female patients who are pregnant, nursing, or planning a pregnancy.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Mueller cemented cupsMueller cemented cupsPatients undergo total hip arthroplasty with the implant of the Mueller cemented cup as acetabular component.
Primary Outcome Measures
NameTimeMethod
Clinical progression of Harris Hip Score (HHS) from baseline to 2 years after surgery2 years Follow up

HHS ranges from 0 to 100, being 0 the worst and 100 the best conditions. HHS is reported as 90-100 for excellent results, 80-90 for good, 70-79 for fair, 60-69 for poor, and below 60 for a failed result. The outcome is considered satisfactory for values over 80

Secondary Outcome Measures
NameTimeMethod
Implant survivorship (Kaplan-Meier estimate) at 2 years after surgery2 years FU
Clinical progression of HOOS up to 2 years FU, compared to the baseline6 weeks, 1 year and 2 years FU

Hip disability and osteoarthritis outcome score (HOOS) is a patient-reported outcome measurement, that ranges from 0 to 100, with 100 indicating no symptoms and 0 indicating extreme symptoms

Change in TUG from preoperative up to 2 years FU6 weeks, 1 year and 2 years FU

Timed Up and Go

Clinical progression of HHS up to 1 year FU, compared to the baseline6 weeks, 1 year

Harris Hip Score

Radiographic evaluation and stability assessment of the implant up to 2 years FU6 weeks, 1 year and 2 years FU

Radiographic stability, radiographically detectable complications

Incidence of device-related AE/SAE up to 2 years of follow-up6 weeks, 1 year and 2 years FU

Adverse events and device deficiencies

Trial Locations

Locations (1)

Ospedale San Camillo di Trento

🇮🇹

Trento, TN, Italy

© Copyright 2025. All Rights Reserved by MedPath